Avantax Advisory Services’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.16M | Sell |
89,178
-3,631
| -4% | -$251K | 0.03% | 385 |
|
|
2025
Q1 | $6.44M | Buy |
92,809
+10,956
| +13% | +$761K | 0.04% | 340 |
|
|
2024
Q4 | $7.04M | Sell |
81,853
-7,439
| -8% | -$640K | 0.04% | 305 |
|
|
2024
Q3 | $10.6M | Sell |
89,292
-8,394
| -9% | -$999K | 0.07% | 208 |
|
|
2024
Q2 | $13.9M | Buy |
97,686
+56,040
| +135% | +$8M | 0.1% | 158 |
|
|
2024
Q1 | $5.35M | Buy |
41,646
+6,468
| +18% | +$830K | 0.05% | 295 |
|
|
2023
Q4 | $3.64M | Buy |
35,178
+4,331
| +14% | +$448K | 0.04% | 342 |
|
|
2023
Q3 | $2.81M | Buy |
30,847
+6,459
| +26% | +$587K | 0.03% | 370 |
|
|
2023
Q2 | $1.97M | Buy |
24,388
+4,046
| +20% | +$327K | 0.02% | 456 |
|
|
2023
Q1 | $1.62M | Buy |
20,342
+170
| +0.8% | +$13.5K | 0.02% | 505 |
|
|
2022
Q4 | $1.37M | Buy |
20,172
+1,154
| +6% | +$78.1K | 0.02% | 527 |
|
|
2022
Q3 | $947K | Sell |
19,018
-650
| -3% | -$32.4K | 0.01% | 571 |
|
|
2022
Q2 | $1.1M | Sell |
19,668
-2,058
| -9% | -$115K | 0.02% | 519 |
|
|
2022
Q1 | $1.2M | Buy |
21,726
+3,406
| +19% | +$189K | 0.02% | 493 |
|
|
2021
Q4 | $1.03M | Sell |
18,320
-358
| -2% | -$20.1K | 0.02% | 532 |
|
|
2021
Q3 | $895K | Sell |
18,678
-278
| -1% | -$13.3K | 0.01% | 524 |
|
|
2021
Q2 | $796K | Buy |
18,956
+426
| +2% | +$17.9K | 0.01% | 534 |
|
|
2021
Q1 | $624K | Buy |
18,530
+8,734
| +89% | +$294K | 0.01% | 557 |
|
|
2020
Q4 | $342K | Sell |
9,796
-10,436
| -52% | -$364K | 0.01% | 675 |
|
|
2020
Q3 | $702K | Buy |
20,232
+12,840
| +174% | +$446K | 0.01% | 673 |
|
|
2020
Q2 | $242K | Buy |
7,392
+92
| +1% | +$3.01K | 0.01% | 717 |
|
|
2020
Q1 | $221K | Sell |
7,300
-196
| -3% | -$5.93K | 0.01% | 688 |
|
|
2019
Q4 | $217K | Buy |
+7,496
| New | +$217K | 0.01% | 757 |
|